Alembic receives USFDA’s final approval for Fluphenazine Hydrochloride Tablets

Veerhealth Care secures export order from US Institutional Supplier

The company is planning to expand its plant capacity in in Vapi

Soumya Swaminathan appointed as the Principle Advisor for the National Tuberculosis Elimination Programme

Alembic Pharmaceuticals announces USFDA Final Approval for Bromfenac Ophthalmic Solution, 0.07%

The approved ANDA is therapeutically equivalent to the reference listed drug product

Zydus receives final approval from USFDA for Sacubitril and Valsartan Tablets

Sacubitril and Valsartan combination is used to treat chronic heart failure in adults

Dr. B.N. Gangadhar appointed as Chairperson of the National Medical Commission

Dr. Sanjay Behari, Director of Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, as the President of the Medical Assessment and Rating Board

Alembic Pharmaceuticals announces USFDA final approval for Doxycycline Capsules, 40 mg

Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients

Shilpa Medicare Bio Analytical unit gets "No Action Indicated" classification from USFDA

This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies

CCRAS hosts national consultative meet on traditional medicine

Signs MoUs with Shri Krishna Ayush University and Dabur India

CCRAS to organize national consultative meet on ‘Research Priority Settings in Traditional Medicine’ in collaboration with WHO

The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India